The in vivo phenotypic profile of T cells reactive to severe acute respiratory syndrome (SARS)-CoV-2
antigens remains poorly understood. Conventional methods to detect antigen-…

Effective countermeasures are needed against emerging coronaviruses of pandemic potential,
similar to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Designing …

Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), and the SARS-CoV-2 spike protein is an envelope …

Infection by SARS-CoV-2 involves the attachment of the receptor binding domain (RBD) of
its spike proteins to the ACE2 receptors on the peripheral membrane of host cells. Binding is …

… Petra Mlcochova; Ambika Chadha; Timi Hesselhoj; Jeremy Ramsden; Ravindra K Gupta;
Suwimon Manopwisedjaroen; Sitthivut Charoensutthivarakul; Patompon Wongtrakoongate; …

Circular RNAs (circRNAs) encoded by DNA genomes have been identified across host and
pathogen species as parts of the transcriptome. Accumulating evidences indicate that …

The in vivo phenotypic profile of T cells reactive to severe acute respiratory syndrome (SARS)-CoV-2
antigens remains poorly understood. Conventional methods to detect antigen-…

While all the siRNA drugs on the market target the liver, the lungs offer a variety of currently
undruggable targets which could potentially be treated with RNA therapeutics. Hence, local, …

SARS-CoV-2 has been the cause of a global pandemic since 2019 and remains a medical
urgency. siRNA-based therapies are a promising strategy to fight viral infections. By targeting …

A promising approach to tackle the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
could be small interfering (si)RNAs. So far it is unclear, which viral replication steps …